CA2633515C - Compositions et procedes pour le traitement dermique de la douleur - Google Patents

Compositions et procedes pour le traitement dermique de la douleur Download PDF

Info

Publication number: CA2633515C
Authority: CA; Canada
Prior art keywords: formulation; volatile solvent; pain; drug; solvent system
Prior art date: 2005-12-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CA2633515A

Other languages

English (en)

Other versions

CA2633515A1 (fr

Inventor

Jie Zhang

Sanjay Sharma

Kevin S. Warner

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Nuvo Research Inc

Original Assignee

ZARS Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-12-14

Filing date

2006-12-14

Publication date

2011-10-18

2006-12-14 Application filed by ZARS Pharma Inc filed Critical ZARS Pharma Inc

2006-12-14 Priority to CA2747845A priority Critical patent/CA2747845C/fr

2007-06-21 Publication of CA2633515A1 publication Critical patent/CA2633515A1/fr

2011-10-18 Application granted granted Critical

2011-10-18 Publication of CA2633515C publication Critical patent/CA2633515C/fr

Status Expired - Fee Related legal-status Critical Current

2026-12-14 Anticipated expiration legal-status Critical

Links

239000000203 mixture Substances 0.000 title claims abstract description 486
208000002193 Pain Diseases 0.000 title claims abstract description 59
238000000034 method Methods 0.000 title description 35
239000002904 solvent Substances 0.000 claims abstract description 492
238000009472 formulation Methods 0.000 claims abstract description 428
239000003814 drug Substances 0.000 claims abstract description 219
229940079593 drug Drugs 0.000 claims abstract description 218
239000003795 chemical substances by application Substances 0.000 claims abstract description 110
238000001704 evaporation Methods 0.000 claims abstract description 53
208000004296 neuralgia Diseases 0.000 claims abstract description 53
230000008020 evaporation Effects 0.000 claims abstract description 52
208000021722 neuropathic pain Diseases 0.000 claims abstract description 52
206010028391 Musculoskeletal Pain Diseases 0.000 claims abstract description 46
206010061218 Inflammation Diseases 0.000 claims abstract description 40
230000004054 inflammatory process Effects 0.000 claims abstract description 40
230000002459 sustained effect Effects 0.000 claims abstract description 29
230000004907 flux Effects 0.000 claims description 186
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 148
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 131
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 127
XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 claims description 118
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 61
239000000853 adhesive Substances 0.000 claims description 60
ZKMNUMMKYBVTFN-HNNXBMFYSA-N (S)-ropivacaine Chemical compound CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C ZKMNUMMKYBVTFN-HNNXBMFYSA-N 0.000 claims description 59
230000001070 adhesive effect Effects 0.000 claims description 58
229960001549 ropivacaine Drugs 0.000 claims description 56
239000004372 Polyvinyl alcohol Substances 0.000 claims description 53
229920002451 polyvinyl alcohol Polymers 0.000 claims description 53
229940068984 polyvinyl alcohol Drugs 0.000 claims description 53
235000011187 glycerol Nutrition 0.000 claims description 52
229960000991 ketoprofen Drugs 0.000 claims description 50
DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 claims description 48
239000004615 ingredient Substances 0.000 claims description 42
239000003981 vehicle Substances 0.000 claims description 42
-1 cytopentasiloxane Chemical compound 0.000 claims description 40
229960004063 propylene glycol Drugs 0.000 claims description 36
235000013772 propylene glycol Nutrition 0.000 claims description 36
239000003589 local anesthetic agent Substances 0.000 claims description 31
229920001223 polyethylene glycol Polymers 0.000 claims description 29
URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 claims description 28
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 26
229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims description 26
NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 claims description 24
229960004194 lidocaine Drugs 0.000 claims description 24
GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 23
230000001427 coherent effect Effects 0.000 claims description 23
229960004418 trolamine Drugs 0.000 claims description 23
229920000642 polymer Polymers 0.000 claims description 22
239000002202 Polyethylene glycol Substances 0.000 claims description 20
229920001577 copolymer Polymers 0.000 claims description 20
235000014113 dietary fatty acids Nutrition 0.000 claims description 20
239000000194 fatty acid Substances 0.000 claims description 20
229930195729 fatty acid Natural products 0.000 claims description 20
230000036961 partial effect Effects 0.000 claims description 19
GKCBAIGFKIBETG-UHFFFAOYSA-N tetracaine Chemical compound CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 GKCBAIGFKIBETG-UHFFFAOYSA-N 0.000 claims description 19
229960000836 amitriptyline Drugs 0.000 claims description 18
DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 claims description 18
229960002372 tetracaine Drugs 0.000 claims description 18
YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 claims description 17
KRMDCWKBEZIMAB-UHFFFAOYSA-N amitriptyline Chemical compound C1CC2=CC=CC=C2C(=CCCN(C)C)C2=CC=CC=C21 KRMDCWKBEZIMAB-UHFFFAOYSA-N 0.000 claims description 17
229960003299 ketamine Drugs 0.000 claims description 17
229920006395 saturated elastomer Polymers 0.000 claims description 16
YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 claims description 14
239000001087 glyceryl triacetate Substances 0.000 claims description 14
235000013773 glyceryl triacetate Nutrition 0.000 claims description 14
239000007787 solid Substances 0.000 claims description 14
229960002622 triacetin Drugs 0.000 claims description 14
229960001259 diclofenac Drugs 0.000 claims description 13
239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims description 13
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 12
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 12
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
239000007788 liquid Substances 0.000 claims description 12
150000003431 steroids Chemical class 0.000 claims description 12
238000005406 washing Methods 0.000 claims description 12
OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims description 11
229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 11
235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 11
230000037317 transdermal delivery Effects 0.000 claims description 11
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 10
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 10
VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical compound CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 claims description 10
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 10
239000000556 agonist Substances 0.000 claims description 10
229960005015 local anesthetics Drugs 0.000 claims description 10
ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 9
LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 claims description 9
ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 9
239000001856 Ethyl cellulose Substances 0.000 claims description 9
235000019325 ethyl cellulose Nutrition 0.000 claims description 9
229920001249 ethyl cellulose Polymers 0.000 claims description 9
210000001145 finger joint Anatomy 0.000 claims description 9
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 9
239000004014 plasticizer Substances 0.000 claims description 9
238000009835 boiling Methods 0.000 claims description 8
239000004359 castor oil Substances 0.000 claims description 8
BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 8
210000003127 knee Anatomy 0.000 claims description 8
239000003921 oil Substances 0.000 claims description 8
235000019198 oils Nutrition 0.000 claims description 8
229920005989 resin Polymers 0.000 claims description 8
239000011347 resin Substances 0.000 claims description 8
210000000707 wrist Anatomy 0.000 claims description 8
108010010803 Gelatin Proteins 0.000 claims description 7
206010040880 Skin irritation Diseases 0.000 claims description 7
230000015572 biosynthetic process Effects 0.000 claims description 7
229960002504 capsaicin Drugs 0.000 claims description 7
235000017663 capsaicin Nutrition 0.000 claims description 7
210000001513 elbow Anatomy 0.000 claims description 7
239000008273 gelatin Substances 0.000 claims description 7
229920000159 gelatin Polymers 0.000 claims description 7
235000019322 gelatine Nutrition 0.000 claims description 7
235000011852 gelatine desserts Nutrition 0.000 claims description 7
ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 7
230000036556 skin irritation Effects 0.000 claims description 7
231100000475 skin irritation Toxicity 0.000 claims description 7
239000003029 tricyclic antidepressant agent Substances 0.000 claims description 7
WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 6
GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 6
LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 claims description 6
LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 6
HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims description 6
102000049773 5-HT2A Serotonin Receptor Human genes 0.000 claims description 6
108010072564 5-HT2A Serotonin Receptor Proteins 0.000 claims description 6
QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 6
229940124638 COX inhibitor Drugs 0.000 claims description 6
XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims description 6
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 6
239000005642 Oleic acid Substances 0.000 claims description 6
ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 6
229940123445 Tricyclic antidepressant Drugs 0.000 claims description 6
SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 claims description 6
229960003150 bupivacaine Drugs 0.000 claims description 6
235000019438 castor oil Nutrition 0.000 claims description 6
150000001875 compounds Chemical class 0.000 claims description 6
229940086555 cyclomethicone Drugs 0.000 claims description 6
SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 6
150000004665 fatty acids Chemical class 0.000 claims description 6
ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 6
QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 6
FPCCSQOGAWCVBH-UHFFFAOYSA-N ketanserin Chemical compound C1=CC(F)=CC=C1C(=O)C1CCN(CCN2C(C3=CC=CC=C3NC2=O)=O)CC1 FPCCSQOGAWCVBH-UHFFFAOYSA-N 0.000 claims description 6
229960005417 ketanserin Drugs 0.000 claims description 6
239000002464 receptor antagonist Substances 0.000 claims description 6
229940044551 receptor antagonist Drugs 0.000 claims description 6
235000015112 vegetable and seed oil Nutrition 0.000 claims description 6
NSGXIBWMJZWTPY-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropane Chemical compound FC(F)(F)CC(F)(F)F NSGXIBWMJZWTPY-UHFFFAOYSA-N 0.000 claims description 5
LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 claims description 5
229920002367 Polyisobutene Polymers 0.000 claims description 5
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 5
239000001273 butane Substances 0.000 claims description 5
229920001971 elastomer Polymers 0.000 claims description 5
LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 claims description 5
229940093471 ethyl oleate Drugs 0.000 claims description 5
IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 claims description 5
239000001267 polyvinylpyrrolidone Substances 0.000 claims description 5
ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 claims description 4
YFMFNYKEUDLDTL-UHFFFAOYSA-N 1,1,1,2,3,3,3-heptafluoropropane Chemical compound FC(F)(F)C(F)C(F)(F)F YFMFNYKEUDLDTL-UHFFFAOYSA-N 0.000 claims description 4
NPNPZTNLOVBDOC-UHFFFAOYSA-N 1,1-difluoroethane Chemical compound CC(F)F NPNPZTNLOVBDOC-UHFFFAOYSA-N 0.000 claims description 4
SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 claims description 4
108010076119 Caseins Proteins 0.000 claims description 4
102000011632 Caseins Human genes 0.000 claims description 4
229920002261 Corn starch Polymers 0.000 claims description 4
NIQCNGHVCWTJSM-UHFFFAOYSA-N Dimethyl phthalate Chemical compound COC(=O)C1=CC=CC=C1C(=O)OC NIQCNGHVCWTJSM-UHFFFAOYSA-N 0.000 claims description 4
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 4
CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 4
BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 claims description 4
VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims description 4
SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 4
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 4
229920003171 Poly (ethylene oxide) Chemical class 0.000 claims description 4
229920002614 Polyether block amide Polymers 0.000 claims description 4
ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 claims description 4
RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 4
235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 4
241001135917 Vitellaria paradoxa Species 0.000 claims description 4
239000002253 acid Substances 0.000 claims description 4
210000003423 ankle Anatomy 0.000 claims description 4
229920002678 cellulose Polymers 0.000 claims description 4
239000001913 cellulose Substances 0.000 claims description 4
229960000541 cetyl alcohol Drugs 0.000 claims description 4
OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 claims description 4
239000010636 coriander oil Substances 0.000 claims description 4
235000005687 corn oil Nutrition 0.000 claims description 4
239000008120 corn starch Substances 0.000 claims description 4
229960003957 dexamethasone Drugs 0.000 claims description 4
UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims description 4
FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 claims description 4
229940008099 dimethicone Drugs 0.000 claims description 4
239000004205 dimethyl polysiloxane Substances 0.000 claims description 4
235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 4
RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 claims description 4
125000005456 glyceride group Chemical group 0.000 claims description 4
235000012907 honey Nutrition 0.000 claims description 4
MLFHJEHSLIIPHL-UHFFFAOYSA-N isoamyl acetate Chemical compound CC(C)CCOC(C)=O MLFHJEHSLIIPHL-UHFFFAOYSA-N 0.000 claims description 4
XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 claims description 4
239000002480 mineral oil Substances 0.000 claims description 4
235000010446 mineral oil Nutrition 0.000 claims description 4
230000007935 neutral effect Effects 0.000 claims description 4
229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 4
229940002612 prodrug Drugs 0.000 claims description 4
239000000651 prodrug Substances 0.000 claims description 4
BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 4
229940057910 shea butter Drugs 0.000 claims description 4
239000004094 surface-active agent Substances 0.000 claims description 4
HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 claims description 4
150000003626 triacylglycerols Chemical class 0.000 claims description 4
239000008158 vegetable oil Substances 0.000 claims description 4
LVGUZGTVOIAKKC-UHFFFAOYSA-N 1,1,1,2-tetrafluoroethane Chemical compound FCC(F)(F)F LVGUZGTVOIAKKC-UHFFFAOYSA-N 0.000 claims description 3
RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 claims description 3
GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 claims description 3
HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 claims description 3
235000019482 Palm oil Nutrition 0.000 claims description 3
229920002494 Zein Polymers 0.000 claims description 3
239000013543 active substance Substances 0.000 claims description 3
125000001931 aliphatic group Chemical group 0.000 claims description 3
125000000217 alkyl group Chemical group 0.000 claims description 3
125000003118 aryl group Chemical group 0.000 claims description 3
229960002903 benzyl benzoate Drugs 0.000 claims description 3
229960002896 clonidine Drugs 0.000 claims description 3
239000003240 coconut oil Substances 0.000 claims description 3
235000019864 coconut oil Nutrition 0.000 claims description 3
239000011928 denatured alcohol Substances 0.000 claims description 3
150000002314 glycerols Chemical class 0.000 claims description 3
FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 claims description 3
XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 claims description 3
229940049964 oleate Drugs 0.000 claims description 3
239000002540 palm oil Substances 0.000 claims description 3
210000001226 toe joint Anatomy 0.000 claims description 3
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 3
229960000281 trometamol Drugs 0.000 claims description 3
229920002554 vinyl polymer Polymers 0.000 claims description 3
239000005019 zein Substances 0.000 claims description 3
229940093612 zein Drugs 0.000 claims description 3
PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 2
XCNILYKGVJTUMZ-DFWYDOINSA-N (2s)-5-oxopyrrolidine-2-carboxylic acid;sodium Chemical compound [Na].OC(=O)[C@@H]1CCC(=O)N1 XCNILYKGVJTUMZ-DFWYDOINSA-N 0.000 claims description 2
MEJYDZQQVZJMPP-ULAWRXDQSA-N (3s,3ar,6r,6ar)-3,6-dimethoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan Chemical compound CO[C@H]1CO[C@@H]2[C@H](OC)CO[C@@H]21 MEJYDZQQVZJMPP-ULAWRXDQSA-N 0.000 claims description 2
YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 claims description 2
KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 claims description 2
ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 claims description 2
ZWVMLYRJXORSEP-UHFFFAOYSA-N 1,2,6-Hexanetriol Chemical compound OCCCCC(O)CO ZWVMLYRJXORSEP-UHFFFAOYSA-N 0.000 claims description 2
CHRJZRDFSQHIFI-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;styrene Chemical compound C=CC1=CC=CC=C1.C=CC1=CC=CC=C1C=C CHRJZRDFSQHIFI-UHFFFAOYSA-N 0.000 claims description 2
OKMWKBLSFKFYGZ-UHFFFAOYSA-N 1-behenoylglycerol Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)CO OKMWKBLSFKFYGZ-UHFFFAOYSA-N 0.000 claims description 2
AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims description 2
VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 2
ZZNDQCACFUJAKJ-UHFFFAOYSA-N 1-phenyltridecan-1-one Chemical compound CCCCCCCCCCCCC(=O)C1=CC=CC=C1 ZZNDQCACFUJAKJ-UHFFFAOYSA-N 0.000 claims description 2
KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical compound CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 claims description 2
FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 claims description 2
LVDXDNDMOQYDMZ-UHFFFAOYSA-N 2-[2-(2-phenylmethoxypropoxy)propoxy]propyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(C)OCC(C)OCC(C)OCc1ccccc1 LVDXDNDMOQYDMZ-UHFFFAOYSA-N 0.000 claims description 2
ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 claims description 2
QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 claims description 2
MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 claims description 2
XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 claims description 2
RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 claims description 2
NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 2
NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical group OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 2
241000251468 Actinopterygii Species 0.000 claims description 2
235000002961 Aloe barbadensis Nutrition 0.000 claims description 2
244000144927 Aloe barbadensis Species 0.000 claims description 2
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 2
239000005711 Benzoic acid Substances 0.000 claims description 2
239000004255 Butylated hydroxyanisole Substances 0.000 claims description 2
229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
229920000623 Cellulose acetate phthalate Polymers 0.000 claims description 2
NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 claims description 2
244000037364 Cinnamomum aromaticum Species 0.000 claims description 2
235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 2
244000007835 Cyamopsis tetragonoloba Species 0.000 claims description 2
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
229920001353 Dextrin Polymers 0.000 claims description 2
239000004375 Dextrin Substances 0.000 claims description 2
239000005770 Eugenol Substances 0.000 claims description 2
108010068370 Glutens Proteins 0.000 claims description 2
239000004348 Glyceryl diacetate Substances 0.000 claims description 2
229920002907 Guar gum Polymers 0.000 claims description 2
239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 2
229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 2
229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 2
239000004166 Lanolin Substances 0.000 claims description 2
235000019501 Lemon oil Nutrition 0.000 claims description 2
241000144217 Limnanthes alba Species 0.000 claims description 2
229920000161 Locust bean gum Polymers 0.000 claims description 2
235000018330 Macadamia integrifolia Nutrition 0.000 claims description 2
235000003800 Macadamia tetraphylla Nutrition 0.000 claims description 2
240000000912 Macadamia tetraphylla Species 0.000 claims description 2
CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims description 2
229920000881 Modified starch Polymers 0.000 claims description 2
235000019502 Orange oil Nutrition 0.000 claims description 2
235000019483 Peanut oil Nutrition 0.000 claims description 2
239000004264 Petrolatum Substances 0.000 claims description 2
235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 2
235000011613 Pinus brutia Nutrition 0.000 claims description 2
241000018646 Pinus brutia Species 0.000 claims description 2
RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 2
239000004721 Polyphenylene oxide Substances 0.000 claims description 2
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 2
UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 claims description 2
KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 claims description 2
229920001800 Shellac Polymers 0.000 claims description 2
IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 claims description 2
241000779819 Syncarpia glomulifera Species 0.000 claims description 2
BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims description 2
DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 claims description 2
235000021307 Triticum Nutrition 0.000 claims description 2
244000098338 Triticum aestivum Species 0.000 claims description 2
XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 claims description 2
229930003427 Vitamin E Natural products 0.000 claims description 2
150000001252 acrylic acid derivatives Chemical class 0.000 claims description 2
229920006243 acrylic copolymer Polymers 0.000 claims description 2
150000001298 alcohols Chemical class 0.000 claims description 2
125000002877 alkyl aryl group Chemical group 0.000 claims description 2
235000011399 aloe vera Nutrition 0.000 claims description 2
229940024606 amino acid Drugs 0.000 claims description 2
150000001413 amino acids Chemical class 0.000 claims description 2
239000010617 anise oil Substances 0.000 claims description 2
239000005557 antagonist Substances 0.000 claims description 2
229940125681 anticonvulsant agent Drugs 0.000 claims description 2
239000001961 anticonvulsive agent Substances 0.000 claims description 2
239000010477 apricot oil Substances 0.000 claims description 2
DZGUJOWBVDZNNF-UHFFFAOYSA-N azanium;2-methylprop-2-enoate Chemical compound [NH4+].CC(=C)C([O-])=O DZGUJOWBVDZNNF-UHFFFAOYSA-N 0.000 claims description 2
OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 claims description 2
235000013871 bee wax Nutrition 0.000 claims description 2
229940092738 beeswax Drugs 0.000 claims description 2
239000012166 beeswax Substances 0.000 claims description 2
235000010233 benzoic acid Nutrition 0.000 claims description 2
DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 claims description 2
235000019282 butylated hydroxyanisole Nutrition 0.000 claims description 2
CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 claims description 2
229940043253 butylated hydroxyanisole Drugs 0.000 claims description 2
108010033929 calcium caseinate Proteins 0.000 claims description 2
239000004204 candelilla wax Substances 0.000 claims description 2
235000013868 candelilla wax Nutrition 0.000 claims description 2
229940073532 candelilla wax Drugs 0.000 claims description 2
235000013736 caramel Nutrition 0.000 claims description 2
235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
229940096529 carboxypolymethylene Drugs 0.000 claims description 2
239000004203 carnauba wax Substances 0.000 claims description 2
235000013869 carnauba wax Nutrition 0.000 claims description 2
229940082483 carnauba wax Drugs 0.000 claims description 2
235000010418 carrageenan Nutrition 0.000 claims description 2
239000000679 carrageenan Substances 0.000 claims description 2
229920001525 carrageenan Polymers 0.000 claims description 2
229940113118 carrageenan Drugs 0.000 claims description 2
239000005018 casein Substances 0.000 claims description 2
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 2
229940071162 caseinate Drugs 0.000 claims description 2
235000021240 caseins Nutrition 0.000 claims description 2
229920002301 cellulose acetate Polymers 0.000 claims description 2
229940081734 cellulose acetate phthalate Drugs 0.000 claims description 2
229940073669 ceteareth 20 Drugs 0.000 claims description 2
229940081733 cetearyl alcohol Drugs 0.000 claims description 2
229960004926 chlorobutanol Drugs 0.000 claims description 2
229940117916 cinnamic aldehyde Drugs 0.000 claims description 2
KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 claims description 2
239000010630 cinnamon oil Substances 0.000 claims description 2
239000001279 citrus aurantifolia swingle expressed oil Substances 0.000 claims description 2
239000010634 clove oil Substances 0.000 claims description 2
235000019868 cocoa butter Nutrition 0.000 claims description 2
229940110456 cocoa butter Drugs 0.000 claims description 2
239000002285 corn oil Substances 0.000 claims description 2
235000012343 cottonseed oil Nutrition 0.000 claims description 2
239000002385 cottonseed oil Substances 0.000 claims description 2
229930003836 cresol Natural products 0.000 claims description 2
GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 claims description 2
235000019425 dextrin Nutrition 0.000 claims description 2
229940099822 di-ppg-2 myreth-10 adipate Drugs 0.000 claims description 2
206010012601 diabetes mellitus Diseases 0.000 claims description 2
229940099371 diacetylated monoglycerides Drugs 0.000 claims description 2
ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 claims description 2
FBSAITBEAPNWJG-UHFFFAOYSA-N dimethyl phthalate Natural products CC(=O)OC1=CC=CC=C1OC(C)=O FBSAITBEAPNWJG-UHFFFAOYSA-N 0.000 claims description 2
229960001826 dimethylphthalate Drugs 0.000 claims description 2
PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 2
QQQMUBLXDAFBRH-UHFFFAOYSA-N dodecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)O QQQMUBLXDAFBRH-UHFFFAOYSA-N 0.000 claims description 2
MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 claims description 2
150000002148 esters Chemical class 0.000 claims description 2
229960004667 ethyl cellulose Drugs 0.000 claims description 2
239000005038 ethylene vinyl acetate Substances 0.000 claims description 2
239000010642 eucalyptus oil Substances 0.000 claims description 2
229940044949 eucalyptus oil Drugs 0.000 claims description 2
229960002217 eugenol Drugs 0.000 claims description 2
239000000284 extract Substances 0.000 claims description 2
239000003925 fat Substances 0.000 claims description 2
235000019197 fats Nutrition 0.000 claims description 2
150000002191 fatty alcohols Chemical class 0.000 claims description 2
235000019688 fish Nutrition 0.000 claims description 2
239000000796 flavoring agent Substances 0.000 claims description 2
235000019634 flavors Nutrition 0.000 claims description 2
235000011389 fruit/vegetable juice Nutrition 0.000 claims description 2
WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 2
235000020708 ginger extract Nutrition 0.000 claims description 2
229940002508 ginger extract Drugs 0.000 claims description 2
229930182478 glucoside Natural products 0.000 claims description 2
235000021312 gluten Nutrition 0.000 claims description 2
RZRNAYUHWVFMIP-HXUWFJFHSA-N glycerol monolinoleate Natural products CCCCCCCCC=CCCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-HXUWFJFHSA-N 0.000 claims description 2
229940049654 glyceryl behenate Drugs 0.000 claims description 2
235000019443 glyceryl diacetate Nutrition 0.000 claims description 2
229940074046 glyceryl laurate Drugs 0.000 claims description 2
229940075529 glyceryl stearate Drugs 0.000 claims description 2
239000000665 guar gum Substances 0.000 claims description 2
235000010417 guar gum Nutrition 0.000 claims description 2
229960002154 guar gum Drugs 0.000 claims description 2
IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 claims description 2
UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 claims description 2
IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 claims description 2
235000019534 high fructose corn syrup Nutrition 0.000 claims description 2
229940071826 hydroxyethyl cellulose Drugs 0.000 claims description 2
235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 2
229920003063 hydroxymethyl cellulose Polymers 0.000 claims description 2
229940031574 hydroxymethyl cellulose Drugs 0.000 claims description 2
235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 2
239000001863 hydroxypropyl cellulose Substances 0.000 claims description 2
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 2
239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 2
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 2
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 2
229940071676 hydroxypropylcellulose Drugs 0.000 claims description 2
229940117955 isoamyl acetate Drugs 0.000 claims description 2
229940074928 isopropyl myristate Drugs 0.000 claims description 2
235000019388 lanolin Nutrition 0.000 claims description 2
229940039717 lanolin Drugs 0.000 claims description 2
229940070765 laurate Drugs 0.000 claims description 2
239000010501 lemon oil Substances 0.000 claims description 2
235000001510 limonene Nutrition 0.000 claims description 2
229940087305 limonene Drugs 0.000 claims description 2
235000010420 locust bean gum Nutrition 0.000 claims description 2
239000000711 locust bean gum Substances 0.000 claims description 2
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims description 2
239000011976 maleic acid Substances 0.000 claims description 2
MBKDYNNUVRNNRF-UHFFFAOYSA-N medronic acid Chemical compound OP(O)(=O)CP(O)(O)=O MBKDYNNUVRNNRF-UHFFFAOYSA-N 0.000 claims description 2
229960003074 medronic acid Drugs 0.000 claims description 2
239000001525 mentha piperita l. herb oil Substances 0.000 claims description 2
239000001683 mentha spicata herb oil Substances 0.000 claims description 2
229920000609 methyl cellulose Polymers 0.000 claims description 2
235000010981 methylcellulose Nutrition 0.000 claims description 2
239000001923 methylcellulose Substances 0.000 claims description 2
239000004200 microcrystalline wax Substances 0.000 claims description 2
235000019808 microcrystalline wax Nutrition 0.000 claims description 2
235000013336 milk Nutrition 0.000 claims description 2
239000008267 milk Substances 0.000 claims description 2
210000004080 milk Anatomy 0.000 claims description 2
229940042472 mineral oil Drugs 0.000 claims description 2
239000001627 myristica fragrans houtt. fruit oil Substances 0.000 claims description 2
229940043348 myristyl alcohol Drugs 0.000 claims description 2
239000010466 nut oil Substances 0.000 claims description 2
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 2
KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 claims description 2
WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 claims description 2
WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 2
XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 claims description 2
229940055577 oleyl alcohol Drugs 0.000 claims description 2
239000010502 orange oil Substances 0.000 claims description 2
RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 claims description 2
239000000312 peanut oil Substances 0.000 claims description 2
235000019477 peppermint oil Nutrition 0.000 claims description 2
235000019271 petrolatum Nutrition 0.000 claims description 2
229940066842 petrolatum Drugs 0.000 claims description 2
229940057874 phenyl trimethicone Drugs 0.000 claims description 2
239000001739 pinus spp. Substances 0.000 claims description 2
229960005455 polacrilin Drugs 0.000 claims description 2
229960000502 poloxamer Drugs 0.000 claims description 2
229920001983 poloxamer Polymers 0.000 claims description 2
229920001432 poly(L-lactide) Polymers 0.000 claims description 2
229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 claims description 2
229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 claims description 2
229920000570 polyether Polymers 0.000 claims description 2
229920001451 polypropylene glycol Polymers 0.000 claims description 2
229920001296 polysiloxane Polymers 0.000 claims description 2
229920003009 polyurethane dispersion Polymers 0.000 claims description 2
229920002689 polyvinyl acetate Polymers 0.000 claims description 2
239000011118 polyvinyl acetate Substances 0.000 claims description 2
229940100467 polyvinyl acetate phthalate Drugs 0.000 claims description 2
239000011591 potassium Substances 0.000 claims description 2
229910052700 potassium Inorganic materials 0.000 claims description 2
229960003975 potassium Drugs 0.000 claims description 2
229940095106 ppg-3 benzyl ether myristate Drugs 0.000 claims description 2
239000001294 propane Substances 0.000 claims description 2
235000018102 proteins Nutrition 0.000 claims description 2
102000004169 proteins and genes Human genes 0.000 claims description 2
108090000623 proteins and genes Proteins 0.000 claims description 2
ARIWANIATODDMH-UHFFFAOYSA-N rac-1-monolauroylglycerol Chemical compound CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 claims description 2
DCBSHORRWZKAKO-UHFFFAOYSA-N rac-1-monomyristoylglycerol Chemical compound CCCCCCCCCCCCCC(=O)OCC(O)CO DCBSHORRWZKAKO-UHFFFAOYSA-N 0.000 claims description 2
239000008159 sesame oil Substances 0.000 claims description 2
235000011803 sesame oil Nutrition 0.000 claims description 2
239000004208 shellac Substances 0.000 claims description 2
ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 claims description 2
229940113147 shellac Drugs 0.000 claims description 2
235000013874 shellac Nutrition 0.000 claims description 2
238000004904 shortening Methods 0.000 claims description 2
229940080237 sodium caseinate Drugs 0.000 claims description 2
229940045920 sodium pyrrolidone carboxylate Drugs 0.000 claims description 2
HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 claims description 2
229940035044 sorbitan monolaurate Drugs 0.000 claims description 2
235000011069 sorbitan monooleate Nutrition 0.000 claims description 2
239000001593 sorbitan monooleate Substances 0.000 claims description 2
229940035049 sorbitan monooleate Drugs 0.000 claims description 2
235000011071 sorbitan monopalmitate Nutrition 0.000 claims description 2
239000001570 sorbitan monopalmitate Substances 0.000 claims description 2
229940031953 sorbitan monopalmitate Drugs 0.000 claims description 2
239000001587 sorbitan monostearate Substances 0.000 claims description 2
229940035048 sorbitan monostearate Drugs 0.000 claims description 2
239000000600 sorbitol Substances 0.000 claims description 2
229960002920 sorbitol Drugs 0.000 claims description 2
239000003549 soybean oil Substances 0.000 claims description 2
235000012424 soybean oil Nutrition 0.000 claims description 2
235000019721 spearmint oil Nutrition 0.000 claims description 2
229940031439 squalene Drugs 0.000 claims description 2
TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims description 2
235000000346 sugar Nutrition 0.000 claims description 2
150000008163 sugars Chemical class 0.000 claims description 2
239000006188 syrup Substances 0.000 claims description 2
235000020357 syrup Nutrition 0.000 claims description 2
229930003799 tocopherol Natural products 0.000 claims description 2
235000010384 tocopherol Nutrition 0.000 claims description 2
229960001295 tocopherol Drugs 0.000 claims description 2
239000011732 tocopherol Substances 0.000 claims description 2
RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 claims description 2
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 2
KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 claims description 2
LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 2
239000001069 triethyl citrate Substances 0.000 claims description 2
VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 claims description 2
235000013769 triethyl citrate Nutrition 0.000 claims description 2
UUJLHYCIMQOUKC-UHFFFAOYSA-N trimethyl-[oxo(trimethylsilylperoxy)silyl]peroxysilane Chemical compound C[Si](C)(C)OO[Si](=O)OO[Si](C)(C)C UUJLHYCIMQOUKC-UHFFFAOYSA-N 0.000 claims description 2
LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 claims description 2
229940036248 turpentine Drugs 0.000 claims description 2
235000013311 vegetables Nutrition 0.000 claims description 2
235000019165 vitamin E Nutrition 0.000 claims description 2
239000011709 vitamin E Substances 0.000 claims description 2
229940046009 vitamin E Drugs 0.000 claims description 2
239000001993 wax Substances 0.000 claims description 2
229920001285 xanthan gum Polymers 0.000 claims description 2
UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 2
GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 2
238000005452 bending Methods 0.000 claims 2
LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 claims 1
206010065016 Post-traumatic pain Diseases 0.000 claims 1
208000004550 Postoperative Pain Diseases 0.000 claims 1
PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 claims 1
BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 claims 1
239000002585 base Substances 0.000 claims 1
POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 claims 1
229940043264 dodecyl sulfate Drugs 0.000 claims 1
229960004756 ethanol Drugs 0.000 claims 1
125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 1
239000012458 free base Substances 0.000 claims 1
229960002969 oleic acid Drugs 0.000 claims 1
WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 claims 1
239000003380 propellant Substances 0.000 claims 1
230000002500 effect on skin Effects 0.000 abstract description 19
230000000699 topical effect Effects 0.000 abstract description 6
208000006820 Arthralgia Diseases 0.000 abstract description 2
210000003491 skin Anatomy 0.000 description 244
239000010410 layer Substances 0.000 description 149
235000019422 polyvinyl alcohol Nutrition 0.000 description 52
210000001503 joint Anatomy 0.000 description 35
239000000243 solution Substances 0.000 description 26
241000699666 Mus <mouse, genus> Species 0.000 description 23
LWZFANDGMFTDAV-BURFUSLBSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-BURFUSLBSA-N 0.000 description 20
238000000338 in vitro Methods 0.000 description 20
210000003205 muscle Anatomy 0.000 description 20
235000011067 sorbitan monolaureate Nutrition 0.000 description 20
238000001035 drying Methods 0.000 description 19
238000005259 measurement Methods 0.000 description 19
239000000546 pharmaceutical excipient Substances 0.000 description 17
239000000126 substance Substances 0.000 description 15
230000008901 benefit Effects 0.000 description 14
230000001186 cumulative effect Effects 0.000 description 14
229920002565 Polyethylene Glycol 400 Polymers 0.000 description 13
238000012360 testing method Methods 0.000 description 12
210000001519 tissue Anatomy 0.000 description 11
229920000742 Cotton Polymers 0.000 description 9
230000000694 effects Effects 0.000 description 9
150000003839 salts Chemical class 0.000 description 9
229920003155 Eudragit® RL 100 Polymers 0.000 description 8
239000006071 cream Substances 0.000 description 8
238000012377 drug delivery Methods 0.000 description 8
UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 8
210000004379 membrane Anatomy 0.000 description 8
239000012528 membrane Substances 0.000 description 8
230000001225 therapeutic effect Effects 0.000 description 8
239000012530 fluid Substances 0.000 description 7
239000000463 material Substances 0.000 description 7
210000000434 stratum corneum Anatomy 0.000 description 7
VVMKVFQYONGBPV-MKWAYWHRSA-N (z)-4-butoxy-4-oxobut-2-enoic acid;methoxyethene Chemical compound COC=C.CCCCOC(=O)\C=C/C(O)=O VVMKVFQYONGBPV-MKWAYWHRSA-N 0.000 description 6
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
239000000499 gel Substances 0.000 description 6
CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 6
230000003993 interaction Effects 0.000 description 6
239000002674 ointment Substances 0.000 description 6
239000000047 product Substances 0.000 description 6
230000009286 beneficial effect Effects 0.000 description 5
238000005336 cracking Methods 0.000 description 5
229960001193 diclofenac sodium Drugs 0.000 description 5
239000002552 dosage form Substances 0.000 description 5
239000006072 paste Substances 0.000 description 5
230000000704 physical effect Effects 0.000 description 5
229940068918 polyethylene glycol 400 Drugs 0.000 description 5
JGMJQSFLQWGYMQ-UHFFFAOYSA-M sodium;2,6-dichloro-n-phenylaniline;acetate Chemical compound [Na+].CC([O-])=O.ClC1=CC=CC(Cl)=C1NC1=CC=CC=C1 JGMJQSFLQWGYMQ-UHFFFAOYSA-M 0.000 description 5
239000011877 solvent mixture Substances 0.000 description 5
229920003134 Eudragit® polymer Polymers 0.000 description 4
QQONPFPTGQHPMA-UHFFFAOYSA-N Propene Chemical group CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 4
239000012790 adhesive layer Substances 0.000 description 4
210000004027 cell Anatomy 0.000 description 4
201000010099 disease Diseases 0.000 description 4
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
238000002474 experimental method Methods 0.000 description 4
239000011521 glass Substances 0.000 description 4
JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 4
230000002981 neuropathic effect Effects 0.000 description 4
229940068196 placebo Drugs 0.000 description 4
239000000902 placebo Substances 0.000 description 4
230000002829 reductive effect Effects 0.000 description 4
230000008719 thickening Effects 0.000 description 4
SLINHMUFWFWBMU-UHFFFAOYSA-N Triisopropanolamine Chemical compound CC(O)CN(CC(C)O)CC(C)O SLINHMUFWFWBMU-UHFFFAOYSA-N 0.000 description 3
239000003443 antiviral agent Substances 0.000 description 3
BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
239000013583 drug formulation Substances 0.000 description 3
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
210000003811 finger Anatomy 0.000 description 3
238000001727 in vivo Methods 0.000 description 3
229960000905 indomethacin Drugs 0.000 description 3
238000012986 modification Methods 0.000 description 3
230000004048 modification Effects 0.000 description 3
210000000056 organ Anatomy 0.000 description 3
201000008482 osteoarthritis Diseases 0.000 description 3
230000035699 permeability Effects 0.000 description 3
239000002953 phosphate buffered saline Substances 0.000 description 3
QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 3
229960002702 piroxicam Drugs 0.000 description 3
206010039073 rheumatoid arthritis Diseases 0.000 description 3
238000003860 storage Methods 0.000 description 3
230000001839 systemic circulation Effects 0.000 description 3
LWNPNOFGINFGGV-UHFFFAOYSA-N 2-(diethylamino)-n-(2,6-dimethylphenyl)acetamide;2-(dimethylamino)ethyl 4-(butylamino)benzoate Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C.CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 LWNPNOFGINFGGV-UHFFFAOYSA-N 0.000 description 2
101100275473 Caenorhabditis elegans ctc-3 gene Proteins 0.000 description 2
229920003149 Eudragit® E 100 Polymers 0.000 description 2
208000000112 Myalgia Diseases 0.000 description 2
ATHHXGZTWNVVOU-UHFFFAOYSA-N N-methylformamide Chemical compound CNC=O ATHHXGZTWNVVOU-UHFFFAOYSA-N 0.000 description 2
101100168274 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cox-3 gene Proteins 0.000 description 2
JNTOCHDNEULJHD-UHFFFAOYSA-N Penciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(CCC(CO)CO)C=N2 JNTOCHDNEULJHD-UHFFFAOYSA-N 0.000 description 2
229920001213 Polysorbate 20 Polymers 0.000 description 2
206010036376 Postherpetic Neuralgia Diseases 0.000 description 2
229920003082 Povidone K 90 Polymers 0.000 description 2
102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 2
108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 description 2
229920002472 Starch Polymers 0.000 description 2
HDOVUKNUBWVHOX-QMMMGPOBSA-N Valacyclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCOC(=O)[C@@H](N)C(C)C)C=N2 HDOVUKNUBWVHOX-QMMMGPOBSA-N 0.000 description 2
208000036142 Viral infection Diseases 0.000 description 2
229960004150 aciclovir Drugs 0.000 description 2
MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 2
230000002411 adverse Effects 0.000 description 2
150000001412 amines Chemical class 0.000 description 2
230000003466 anti-cipated effect Effects 0.000 description 2
206010003246 arthritis Diseases 0.000 description 2
229960002537 betamethasone Drugs 0.000 description 2
UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 description 2
229960001102 betamethasone dipropionate Drugs 0.000 description 2
CIWBQSYVNNPZIQ-XYWKZLDCSA-N betamethasone dipropionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CIWBQSYVNNPZIQ-XYWKZLDCSA-N 0.000 description 2
239000003181 biological factor Substances 0.000 description 2
239000008280 blood Substances 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
NEDGUIRITORSKL-UHFFFAOYSA-N butyl 2-methylprop-2-enoate;2-(dimethylamino)ethyl 2-methylprop-2-enoate;methyl 2-methylprop-2-enoate Chemical compound COC(=O)C(C)=C.CCCCOC(=O)C(C)=C.CN(C)CCOC(=O)C(C)=C NEDGUIRITORSKL-UHFFFAOYSA-N 0.000 description 2
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
230000008859 change Effects 0.000 description 2
230000001684 chronic effect Effects 0.000 description 2
CBGUOGMQLZIXBE-XGQKBEPLSA-N clobetasol propionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CBGUOGMQLZIXBE-XGQKBEPLSA-N 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
238000013461 design Methods 0.000 description 2
210000002310 elbow joint Anatomy 0.000 description 2
230000002708 enhancing effect Effects 0.000 description 2
238000011156 evaluation Methods 0.000 description 2
239000004744 fabric Substances 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
229960000890 hydrocortisone Drugs 0.000 description 2
239000001257 hydrogen Substances 0.000 description 2
229910052739 hydrogen Inorganic materials 0.000 description 2
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
230000000670 limiting effect Effects 0.000 description 2
239000006210 lotion Substances 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
238000002156 mixing Methods 0.000 description 2
210000002346 musculoskeletal system Anatomy 0.000 description 2
210000003739 neck Anatomy 0.000 description 2
239000006174 pH buffer Substances 0.000 description 2
230000037361 pathway Effects 0.000 description 2
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
239000002244 precipitate Substances 0.000 description 2
229960005205 prednisolone Drugs 0.000 description 2
OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 2
229960004618 prednisone Drugs 0.000 description 2
XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 2
230000008569 process Effects 0.000 description 2
125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
238000000926 separation method Methods 0.000 description 2
239000002400 serotonin 2A antagonist Substances 0.000 description 2
239000011734 sodium Substances 0.000 description 2
239000002689 soil Substances 0.000 description 2
239000008107 starch Substances 0.000 description 2
235000019698 starch Nutrition 0.000 description 2
208000024891 symptom Diseases 0.000 description 2
238000012956 testing procedure Methods 0.000 description 2
210000003371 toe Anatomy 0.000 description 2
238000011282 treatment Methods 0.000 description 2
229950008396 ulobetasol propionate Drugs 0.000 description 2
BDSYKGHYMJNPAB-LICBFIPMSA-N ulobetasol propionate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H](C)[C@@](C(=O)CCl)(OC(=O)CC)[C@@]2(C)C[C@@H]1O BDSYKGHYMJNPAB-LICBFIPMSA-N 0.000 description 2
229940093257 valacyclovir Drugs 0.000 description 2
230000009385 viral infection Effects 0.000 description 2
UVHQXWILFGUDTA-LNKPDPKZSA-N (z)-4-ethoxy-4-oxobut-2-enoic acid;methoxyethene Chemical compound COC=C.CCOC(=O)\C=C/C(O)=O UVHQXWILFGUDTA-LNKPDPKZSA-N 0.000 description 1
RPUAEFVSGRNPGI-UHFFFAOYSA-N 1,1,1,2,3,3,3-heptafluoropropane;1,1,1,2-tetrafluoroethane Chemical compound FCC(F)(F)F.FC(F)(F)C(F)C(F)(F)F RPUAEFVSGRNPGI-UHFFFAOYSA-N 0.000 description 1
ILCOCZBHMDEIAI-UHFFFAOYSA-N 2-(2-octadecoxyethoxy)ethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCOCCO ILCOCZBHMDEIAI-UHFFFAOYSA-N 0.000 description 1
SKIIKRJAQOSWFT-UHFFFAOYSA-N 2-[3-[1-(2,2-difluoroethyl)piperidin-4-yl]oxy-4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound FC(CN1CCC(CC1)OC1=NN(C=C1C=1C=NC(=NC=1)NC1CC2=CC=CC=C2C1)CC(=O)N1CC2=C(CC1)NN=N2)F SKIIKRJAQOSWFT-UHFFFAOYSA-N 0.000 description 1
RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
USSIQXCVUWKGNF-UHFFFAOYSA-N 6-(dimethylamino)-4,4-diphenylheptan-3-one Chemical compound C=1C=CC=CC=1C(CC(C)N(C)C)(C(=O)CC)C1=CC=CC=C1 USSIQXCVUWKGNF-UHFFFAOYSA-N 0.000 description 1
LLQHSBBZNDXTIV-UHFFFAOYSA-N 6-[5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-4,5-dihydro-1,2-oxazol-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC1CC(=NO1)C1=CC2=C(NC(O2)=O)C=C1 LLQHSBBZNDXTIV-UHFFFAOYSA-N 0.000 description 1
VHRSUDSXCMQTMA-PJHHCJLFSA-N 6alpha-methylprednisolone Chemical compound C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)CO)CC[C@H]21 VHRSUDSXCMQTMA-PJHHCJLFSA-N 0.000 description 1
208000025978 Athletic injury Diseases 0.000 description 1
208000008035 Back Pain Diseases 0.000 description 1
206010006002 Bone pain Diseases 0.000 description 1
229920002827 CELVOL ® 502 Polymers 0.000 description 1
208000017667 Chronic Disease Diseases 0.000 description 1
102100024452 DNA-directed RNA polymerase III subunit RPC1 Human genes 0.000 description 1
OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
VTUSIVBDOCDNHS-UHFFFAOYSA-N Etidocaine Chemical compound CCCN(CC)C(CC)C(=O)NC1=C(C)C=CC=C1C VTUSIVBDOCDNHS-UHFFFAOYSA-N 0.000 description 1
229920003156 Eudragit® RL PO Polymers 0.000 description 1
208000035874 Excoriation Diseases 0.000 description 1
206010019972 Herpes viral infections Diseases 0.000 description 1
101000689002 Homo sapiens DNA-directed RNA polymerase III subunit RPC1 Proteins 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
238000012404 In vitro experiment Methods 0.000 description 1
ALFGKMXHOUSVAD-UHFFFAOYSA-N Ketobemidone Chemical compound C=1C=CC(O)=CC=1C1(C(=O)CC)CCN(C)CC1 ALFGKMXHOUSVAD-UHFFFAOYSA-N 0.000 description 1
MKXZASYAUGDDCJ-SZMVWBNQSA-N LSM-2525 Chemical compound C1CCC[C@H]2[C@@]3([H])N(C)CC[C@]21C1=CC(OC)=CC=C1C3 MKXZASYAUGDDCJ-SZMVWBNQSA-N 0.000 description 1
208000008930 Low Back Pain Diseases 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
206010049816 Muscle tightness Diseases 0.000 description 1
101100208473 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) lcm-2 gene Proteins 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
NKSOSPOXQKNIKJ-CLFAGFIQSA-N Polyoxyethylene dioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCOC(=O)CCCCCCC\C=C/CCCCCCCC NKSOSPOXQKNIKJ-CLFAGFIQSA-N 0.000 description 1
239000004792 Prolene Substances 0.000 description 1
206010039792 Seborrhoea Diseases 0.000 description 1
229940124639 Selective inhibitor Drugs 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
210000001015 abdomen Anatomy 0.000 description 1
238000005299 abrasion Methods 0.000 description 1
239000002250 absorbent Substances 0.000 description 1
230000002745 absorbent Effects 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
230000009692 acute damage Effects 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
239000000670 adrenergic alpha-2 receptor antagonist Substances 0.000 description 1
DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 1
229960003805 amantadine Drugs 0.000 description 1
229940075534 amino methacrylate copolymer Drugs 0.000 description 1
229940050390 benzoate Drugs 0.000 description 1
230000017531 blood circulation Effects 0.000 description 1
210000000988 bone and bone Anatomy 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
239000006227 byproduct Substances 0.000 description 1
210000003169 central nervous system Anatomy 0.000 description 1
235000013339 cereals Nutrition 0.000 description 1
230000004087 circulation Effects 0.000 description 1
229960002842 clobetasol Drugs 0.000 description 1
229960004703 clobetasol propionate Drugs 0.000 description 1
238000010668 complexation reaction Methods 0.000 description 1
239000002537 cosmetic Substances 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
239000004148 curcumin Substances 0.000 description 1
229960001985 dextromethorphan Drugs 0.000 description 1
XLMALTXPSGQGBX-GCJKJVERSA-N dextropropoxyphene Chemical compound C([C@](OC(=O)CC)([C@H](C)CN(C)C)C=1C=CC=CC=1)C1=CC=CC=C1 XLMALTXPSGQGBX-GCJKJVERSA-N 0.000 description 1
229960004193 dextropropoxyphene Drugs 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 1
229940043276 diisopropanolamine Drugs 0.000 description 1
229940043279 diisopropylamine Drugs 0.000 description 1
239000003684 drug solvent Substances 0.000 description 1
230000009881 electrostatic interaction Effects 0.000 description 1
210000002615 epidermis Anatomy 0.000 description 1
229960003976 etidocaine Drugs 0.000 description 1
229960004396 famciclovir Drugs 0.000 description 1
GGXKWVWZWMLJEH-UHFFFAOYSA-N famcyclovir Chemical compound N1=C(N)N=C2N(CCC(COC(=O)C)COC(C)=O)C=NC2=C1 GGXKWVWZWMLJEH-UHFFFAOYSA-N 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
210000004905 finger nail Anatomy 0.000 description 1
235000021323 fish oil Nutrition 0.000 description 1
210000000245 forearm Anatomy 0.000 description 1
239000013022 formulation composition Substances 0.000 description 1
229910021485 fumed silica Inorganic materials 0.000 description 1
210000004392 genitalia Anatomy 0.000 description 1
239000008169 grapeseed oil Substances 0.000 description 1
210000001624 hip Anatomy 0.000 description 1
150000004677 hydrates Chemical class 0.000 description 1
229930195733 hydrocarbon Natural products 0.000 description 1
150000002430 hydrocarbons Chemical class 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
230000006872 improvement Effects 0.000 description 1
238000010874 in vitro model Methods 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
208000014674 injury Diseases 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
230000007794 irritation Effects 0.000 description 1
229960003029 ketobemidone Drugs 0.000 description 1
239000004922 lacquer Substances 0.000 description 1
210000003041 ligament Anatomy 0.000 description 1
230000007774 longterm Effects 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
BUGYDGFZZOZRHP-UHFFFAOYSA-N memantine Chemical compound C1C(C2)CC3(C)CC1(C)CC2(N)C3 BUGYDGFZZOZRHP-UHFFFAOYSA-N 0.000 description 1
229960004640 memantine Drugs 0.000 description 1
229960001797 methadone Drugs 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
229960004584 methylprednisolone Drugs 0.000 description 1
210000002200 mouth mucosa Anatomy 0.000 description 1
210000004877 mucosa Anatomy 0.000 description 1
210000002850 nasal mucosa Anatomy 0.000 description 1
210000000653 nervous system Anatomy 0.000 description 1
230000037312 oily skin Effects 0.000 description 1
239000004006 olive oil Substances 0.000 description 1
235000008390 olive oil Nutrition 0.000 description 1
238000005457 optimization Methods 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
239000003973 paint Substances 0.000 description 1
229960001179 penciclovir Drugs 0.000 description 1
230000037368 penetrate the skin Effects 0.000 description 1
210000001428 peripheral nervous system Anatomy 0.000 description 1
239000012466 permeate Substances 0.000 description 1
239000000825 pharmaceutical preparation Substances 0.000 description 1
229940127557 pharmaceutical product Drugs 0.000 description 1
230000010399 physical interaction Effects 0.000 description 1
238000013031 physical testing Methods 0.000 description 1
238000000554 physical therapy Methods 0.000 description 1
229920000728 polyester Polymers 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229920000136 polysorbate Polymers 0.000 description 1
229920006316 polyvinylpyrrolidine Polymers 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
229960001807 prilocaine Drugs 0.000 description 1
MVFGUOIZUNYYSO-UHFFFAOYSA-N prilocaine Chemical compound CCCNC(C)C(=O)NC1=CC=CC=C1C MVFGUOIZUNYYSO-UHFFFAOYSA-N 0.000 description 1
238000012545 processing Methods 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000004044 response Effects 0.000 description 1
238000005070 sampling Methods 0.000 description 1
239000012047 saturated solution Substances 0.000 description 1
239000008299 semisolid dosage form Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
210000004872 soft tissue Anatomy 0.000 description 1
238000010099 solid forming Methods 0.000 description 1
239000012453 solvate Substances 0.000 description 1
210000000278 spinal cord Anatomy 0.000 description 1
238000005507 spraying Methods 0.000 description 1
230000007480 spreading Effects 0.000 description 1
238000003892 spreading Methods 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
230000035900 sweating Effects 0.000 description 1
230000002195 synergetic effect Effects 0.000 description 1
239000011885 synergistic combination Substances 0.000 description 1
210000001179 synovial fluid Anatomy 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
210000002435 tendon Anatomy 0.000 description 1
210000004906 toe nail Anatomy 0.000 description 1
239000006208 topical dosage form Substances 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000008733 trauma Effects 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Rheumatology (AREA)
Neurosurgery (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

CA2633515A 2005-12-14 2006-12-14 Compositions et procedes pour le traitement dermique de la douleur Expired - Fee Related CA2633515C (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA2747845A CA2747845C (fr)	2005-12-14	2006-12-14	Compositions et procedes pour le traitement dermique de la douleur

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US75063705P	2005-12-14	2005-12-14
US75051905P	2005-12-14	2005-12-14
US75068305P	2005-12-14	2005-12-14
US60/750,683		2005-12-14
US60/750,637		2005-12-14
US60/750,519		2005-12-14
PCT/US2006/047926 WO2007070679A2 (fr)	2005-12-14	2006-12-14	Compositions et procedes pour le traitement dermique de la douleur

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2747845A Division CA2747845C (fr)	2005-12-14	2006-12-14	Compositions et procedes pour le traitement dermique de la douleur

Publications (2)

Publication Number	Publication Date
CA2633515A1 CA2633515A1 (fr)	2007-06-21
CA2633515C true CA2633515C (fr)	2011-10-18

Family

ID=38163542

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2633515A Expired - Fee Related CA2633515C (fr)	2005-12-14	2006-12-14	Compositions et procedes pour le traitement dermique de la douleur

Country Status (5)

Country	Link
EP (1)	EP1959931A4 (fr)
JP (1)	JP2009524586A (fr)
AU (1)	AU2006326018B2 (fr)
CA (1)	CA2633515C (fr)
WO (1)	WO2007070679A2 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8907153B2 (en)	2004-06-07	2014-12-09	Nuvo Research Inc.	Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US8741332B2 (en)	2004-06-07	2014-06-03	Nuvo Research Inc.	Compositions and methods for dermally treating neuropathic pain
US8741333B2 (en)	2004-06-07	2014-06-03	Nuvo Research Inc.	Compositions and methods for treating dermatitis or psoriasis
US9283177B2 (en) *	2007-01-16	2016-03-15	Juventio, Llc	Topical anesthetic for rapid local anesthesia and method of applying a topical anesthetic
WO2008089242A1 (fr)	2007-01-16	2008-07-24	Dermworx, Incorporated	Anesthésique topique pour anesthésie locale rapide et méthode d'application d'un anesthésique topique
CN101970427A (zh)	2008-02-29	2011-02-09	Vm生物医药公司	治疗疼痛症状及其它失调的方法
CA2730787A1 (fr) *	2008-07-16	2010-01-21	David M. Cohen	Systeme d'apport de medicament topique
US9012477B2 (en) *	2009-01-06	2015-04-21	Nuvo Research Inc.	Method of treating neuropathic pain
US20110086913A1 (en) *	2009-04-01	2011-04-14	Jie Zhang	Methods for treating myofascial, muscle, and/or back pain
CN102427792A (zh)	2009-05-04	2012-04-25	扎斯制药公司	治疗与神经瘤、神经卡压及其他病况相关联的疼痛的方法
US9186334B2 (en)	2009-05-04	2015-11-17	Nuvo Research Inc.	Heat assisted lidocaine and tetracaine for transdermal analgesia
CN102834096A (zh)	2010-01-14	2012-12-19	卢福研究公司	用于疼痛控制的固态成型局部麻醉制剂
US20130324502A1 (en)	2011-02-10	2013-12-05	Moberg Pharma Ab	Novel formulations for dermal, transdermal and mucosal use 1
BR112013028802B1 (pt)	2011-05-10	2021-10-26	Itochu Chemical Frontier Corporation	Curativo adesivo não-aquoso
ES3034911T3 (en)	2011-05-10	2025-08-26	Itochu Chemical Frontier Corp	Non-aqueous patch
US11786455B2 (en)	2011-05-10	2023-10-17	Itochu Chemical Frontier Corporation	Non-aqueous patch
CN103533927A (zh) *	2011-05-26	2014-01-22	诺瓦提斯公司	用于生理学活性成分经皮给药的组合物
CN102302418B (zh) *	2011-09-21	2013-01-23	韩褆	节水型多功能洗手消毒液
LT2823815T (lt)	2011-09-27	2018-08-27	Itochu Chemical Frontier Corporation	Nevandeninis pleistras
CN103142458B (zh) *	2013-01-22	2015-09-09	莱普德制药有限公司	无成瘾性镇痛缓释递药系统的组方与制备方法
GB201317718D0 (en) *	2013-10-07	2013-11-20	Buzzz Pharmaceuticals Ltd	Novel formulation
JP6209749B2 (ja) *	2015-12-10	2017-10-11	伊藤忠ケミカルフロンティア株式会社	非水性貼付剤
US11141387B2 (en)	2017-01-05	2021-10-12	Medrx Co., Ltd.	Memantine-containing transdermally absorbable liquid
EP3720417B1 (fr)	2017-12-04	2023-11-01	Johnson & Johnson Consumer Inc.	Composition d'émulsion topique contenant un médicament anti-inflammatoire non stéroïdien
WO2022167359A1 (fr) *	2021-02-02	2022-08-11	DuPont Nutrition USA, Inc.	Composition de gel aqueux comprenant une éthylcellulose

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AUPN814496A0 (en) *	1996-02-19	1996-03-14	Monash University	Dermal penetration enhancer
US20040018241A1 (en) *	1997-09-26	2004-01-29	Noven Pharmaceuticals, Inc.	Bioadhesive compositions and methods for topical administration of active agents
IL135258A0 (en) *	1997-09-26	2001-05-20	Noven Pharma	Bioadhesive compositions and methods for topical administration of active agents
US6528086B2 (en) *	1999-09-28	2003-03-04	Zars, Inc.	Methods and apparatus for drug delivery involving phase changing formulations
AUPQ419099A0 (en) *	1999-11-23	1999-12-16	Ko, Thomas Sai Ying	Novel compositions and methods
US6432415B1 (en) *	1999-12-17	2002-08-13	Axrix Laboratories, Inc.	Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces

2006
- 2006-12-14 JP JP2008545844A patent/JP2009524586A/ja active Pending
- 2006-12-14 WO PCT/US2006/047926 patent/WO2007070679A2/fr not_active Ceased
- 2006-12-14 EP EP06848632A patent/EP1959931A4/fr not_active Withdrawn
- 2006-12-14 AU AU2006326018A patent/AU2006326018B2/en not_active Ceased
- 2006-12-14 CA CA2633515A patent/CA2633515C/fr not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP1959931A2 (fr)	2008-08-27
EP1959931A4 (fr)	2012-08-22
WO2007070679A2 (fr)	2007-06-21
WO2007070679A3 (fr)	2009-01-08
AU2006326018A1 (en)	2007-06-21
AU2006326018B2 (en)	2013-04-18
JP2009524586A (ja)	2009-07-02
CA2633515A1 (fr)	2007-06-21

Legal Events

Date	Code	Title	Description
2006-06-13	EEER	Examination request
2017-01-25	MKLA	Lapsed	Effective date: 20161214

Publication	Publication Date	Title
US8741332B2 (en)	2014-06-03	Compositions and methods for dermally treating neuropathic pain
CA2633515C (fr)	2011-10-18	Compositions et procedes pour le traitement dermique de la douleur
US20070189978A1 (en)	2007-08-16	Compositions and methods for dermally treating musculoskeletal pain
US8741333B2 (en)	2014-06-03	Compositions and methods for treating dermatitis or psoriasis
US20080019927A1 (en)	2008-01-24	Compositions and methods for dermally treating neuropathy with minoxidil
US20120294907A1 (en)	2012-11-22	Two or more solidifying agent-containing compositions and methods for dermal delivery of drugs
CA2633489C (fr)	2013-09-24	Compositions et procedes pour le traitement de conditions dermatologiques
US20070196453A1 (en)	2007-08-23	Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
US20120294926A1 (en)	2012-11-22	Two or more volatile solvent-containing compositions and methods for dermal delivery of drugs
US20100267678A1 (en)	2010-10-21	Flux-enabling compositions and methods for dermal delivery of drugs
US20070189977A1 (en)	2007-08-16	Spray-on formulations and methods for dermal delivery of drugs
US20070196323A1 (en)	2007-08-23	Polyvinyl alcohol-containing compositions and methods for dermal delivery of drugs
US20070196325A1 (en)	2007-08-23	Compositions and methods for dermally treating infections
US20070189980A1 (en)	2007-08-16	Compositions and methods for treating alopecia
WO2007070695A2 (fr)	2007-06-21	Compositions de fluidification et procede pour administrer par voie cutanee des medicaments
US20070196293A1 (en)	2007-08-23	Compositions and methods for treating photo damaged skin
CA2747845C (fr)	2012-10-09	Compositions et procedes pour le traitement dermique de la douleur
CA2633464A1 (fr)	2007-09-07	Compositions et procedes d'administration dermique de medicaments
WO2007070694A2 (fr)	2007-06-21	Formulations pouvant etre pulverisees et procedes pour administrer par voie cutanee des medicaments
HK1175402A (en)	2013-07-05	Flux-enabling compositions and methods for dermal delivery of drugs